Serina Therapeutics Inc (SER)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$2.73+1.49%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · SER
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | — | 0.1 | 0.1 | 3.2 | 0.0 | 0.1 | 0.4 | 1.7 | 1.4 |
| Cost of Revenues | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.4 |
| Gross Profit | — | — | — | 0.1 | 0.0 | 0.1 | 0.3 | 1.5 | 1.0 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 14.1 | 13.2 | 7.5 | 2.4 | 1.0 | 1.5 | 3.7 | 5.9 | 5.8 |
| Operating Income | — | (24.0) | (17.0) | (3.1) | (7.0) | (7.9) | (10.1) | (12.6) | (11.2) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | 0.2 | 0.5 | 4.9 | 3.3 | 1.1 | — | — | — |
| Other Non-Operating Income / Expenses | 4.5 | 4.8 | 5.8 | 8.4 | (3.5) | (0.6) | (0.3) | 0.3 | 3.5 |
| Asset Writedown | — | — | — | 0.0 | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (19.2) | (11.1) | 5.3 | 10.5 | 8.7 | (11.1) | (12.2) | — |
| Income Tax Expense | — | 0.0 | — | 0.0 | — | — | (0.2) | 0.1 | — |
| Earnings from Continuing Operations | — | — | — | — | (10.5) | (8.6) | 0.0 | — | — |
| Net Income | |||||||||
| Minority Interest | — | (0.0) | (0.1) | 0.0 | (0.1) | (0.0) | (0.1) | (0.2) | (0.2) |
| Net Income | (21.2) | (19.2) | (11.1) | 5.3 | (10.5) | (8.7) | (10.9) | (12.2) | (7.5) |
| Per Share | |||||||||
| Basic EPS | (1.29) | (1.91) | (1.51) | 2.36 | (9.70) | (0.23) | — | — | — |
| Diluted EPS | (1.29) | (1.91) | (1.51) | 0.73 | (9.70) | — | — | — | — |
| Basic Weighted Avg Shares | 16.4 | 10.2 | 7.4 | 2.2 | 0.0 | 37.9 | — | — | — |
| Diluted Weighted Avg Shares | 16.4 | 10.2 | 7.4 | 7.4 | 0.0 | — | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (23.9) | (16.9) | (3.0) | — | — | (9.4) | (12.2) | — |
| EBIT | — | (24.0) | (17.0) | (3.1) | (7.0) | (7.9) | (10.1) | (12.6) | (11.2) |
| Effective Tax Rate | — | — | — | 0.0% | — | — | 1.3% | -1.2% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.